ES2992526T3 - Métodos de diagnóstico y dispositivo - Google Patents
Métodos de diagnóstico y dispositivo Download PDFInfo
- Publication number
- ES2992526T3 ES2992526T3 ES17842455T ES17842455T ES2992526T3 ES 2992526 T3 ES2992526 T3 ES 2992526T3 ES 17842455 T ES17842455 T ES 17842455T ES 17842455 T ES17842455 T ES 17842455T ES 2992526 T3 ES2992526 T3 ES 2992526T3
- Authority
- ES
- Spain
- Prior art keywords
- ded
- tear
- tear sample
- physical parameter
- parameter value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002405 diagnostic procedure Methods 0.000 title description 18
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims abstract description 549
- 238000000034 method Methods 0.000 claims abstract description 79
- 238000012545 processing Methods 0.000 claims abstract description 53
- 241001465754 Metazoa Species 0.000 claims abstract description 21
- 238000000518 rheometry Methods 0.000 claims abstract description 17
- 239000012530 fluid Substances 0.000 claims description 63
- 238000005259 measurement Methods 0.000 claims description 27
- 238000010897 surface acoustic wave method Methods 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 40
- 230000002950 deficient Effects 0.000 description 30
- 230000007812 deficiency Effects 0.000 description 22
- 206010013774 Dry eye Diseases 0.000 description 18
- 238000005070 sampling Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 8
- 238000003759 clinical diagnosis Methods 0.000 description 7
- 238000004891 communication Methods 0.000 description 7
- 238000012544 monitoring process Methods 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 6
- 210000004175 meibomian gland Anatomy 0.000 description 6
- 238000004590 computer program Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 206010023642 Lacrimation decreased Diseases 0.000 description 2
- 239000000607 artificial tear Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- KZMRYBLIGYQPPP-UHFFFAOYSA-M 3-[[4-[(2-chlorophenyl)-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)Cl)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 KZMRYBLIGYQPPP-UHFFFAOYSA-M 0.000 description 1
- 102000003752 Lipocalin 1 Human genes 0.000 description 1
- 108010057281 Lipocalin 1 Proteins 0.000 description 1
- 206010065062 Meibomian gland dysfunction Diseases 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 208000023715 Ocular surface disease Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 210000004561 lacrimal apparatus Anatomy 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940051875 mucins Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000012014 optical coherence tomography Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000004488 tear evaporation Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
- G01N11/02—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties by measuring flow of the material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0048—Detecting, measuring or recording by applying mechanical forces or stimuli
- A61B5/0051—Detecting, measuring or recording by applying mechanical forces or stimuli by applying vibrations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
- G01N13/02—Investigating surface tension of liquids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/02—Analysing fluids
- G01N29/022—Fluid sensors based on microsensors, e.g. quartz crystal-microbalance [QCM], surface acoustic wave [SAW] devices, tuning forks, cantilevers, flexural plate wave [FPW] devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/02—Analysing fluids
- G01N29/036—Analysing fluids by measuring frequency or resonance of acoustic waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/14—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object using acoustic emission techniques
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/22—Details, e.g. general constructional or apparatus details
- G01N29/24—Probes
- G01N29/2418—Probes using optoacoustic interaction with the material, e.g. laser radiation, photoacoustics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/44—Processing the detected response signal, e.g. electronic circuits specially adapted therefor
- G01N29/4409—Processing the detected response signal, e.g. electronic circuits specially adapted therefor by comparison
- G01N29/4436—Processing the detected response signal, e.g. electronic circuits specially adapted therefor by comparison with a reference signal
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
- G01N2011/006—Determining flow properties indirectly by measuring other parameters of the system
- G01N2011/0073—Determining flow properties indirectly by measuring other parameters of the system acoustic properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/02—Indexing codes associated with the analysed material
- G01N2291/028—Material parameters
- G01N2291/02827—Elastic parameters, strength or force
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/04—Wave modes and trajectories
- G01N2291/042—Wave modes
- G01N2291/0423—Surface waves, e.g. Rayleigh waves, Love waves
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Acoustics & Sound (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Signal Processing (AREA)
- Eye Examination Apparatus (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016903362A AU2016903362A0 (en) | 2016-08-24 | Diagnostic methods and device | |
| PCT/AU2017/050900 WO2018035569A1 (en) | 2016-08-24 | 2017-08-24 | Diagnostic methods and device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2992526T3 true ES2992526T3 (es) | 2024-12-13 |
Family
ID=61245972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17842455T Active ES2992526T3 (es) | 2016-08-24 | 2017-08-24 | Métodos de diagnóstico y dispositivo |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11397145B2 (enExample) |
| EP (1) | EP3504532B1 (enExample) |
| JP (1) | JP7058013B2 (enExample) |
| AU (1) | AU2017316997B2 (enExample) |
| CA (1) | CA3034608A1 (enExample) |
| ES (1) | ES2992526T3 (enExample) |
| WO (1) | WO2018035569A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102293429B1 (ko) * | 2019-12-26 | 2021-08-26 | 고려대학교 산학협력단 | 안구건조증 유형 구별을 위한 진단 방법 및 진단 장치 |
| DE102020110729A1 (de) | 2020-04-20 | 2021-10-21 | Martin Gmbh | Verfahren und Vorrichtung zur optischen Bestimmung von Tropfenvolumina |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007126391A1 (en) | 2006-04-28 | 2007-11-08 | Singapore Health Services Pte Ltd | Investigation of mucosa dryness conditions |
| JP5511949B2 (ja) | 2009-06-25 | 2014-06-04 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 体液レオロジーを評価するための、作動され表面に付着したポストを使用するための方法及びシステム |
| TWI547522B (zh) * | 2009-07-07 | 2016-09-01 | 愛爾康研究有限公司 | 環氧乙烷環氧丁烷嵌段共聚物組成物 |
| JP5572407B2 (ja) | 2010-01-29 | 2014-08-13 | 京都府公立大学法人 | 眼科装置及び画像分類プログラム |
| PE20130038A1 (es) * | 2010-03-10 | 2013-01-28 | Incyte Corp | Derivados de piperidin-4-il azetidina como inhibidores de jak1 |
| US20130233059A1 (en) * | 2010-06-22 | 2013-09-12 | Royal Melbourne Institute Of Technology | Rheometry instrument utilizing surface acoustic waves |
| US9230062B2 (en) * | 2012-11-06 | 2016-01-05 | 20/20 Vision Center, Llc | Systems and methods for enabling customers to obtain vision and eye health examinations |
| ES2650981B2 (es) * | 2016-07-20 | 2018-05-04 | Ocupharm Diagnostics, Sl | Preparación y uso de un extracto de Artemia salina para tratar la superficie ocular |
| CN113244291A (zh) * | 2016-08-19 | 2021-08-13 | 阿克里维斯塔有限责任公司 | 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物 |
-
2017
- 2017-08-24 JP JP2019510809A patent/JP7058013B2/ja active Active
- 2017-08-24 AU AU2017316997A patent/AU2017316997B2/en active Active
- 2017-08-24 WO PCT/AU2017/050900 patent/WO2018035569A1/en not_active Ceased
- 2017-08-24 CA CA3034608A patent/CA3034608A1/en active Pending
- 2017-08-24 US US16/327,063 patent/US11397145B2/en active Active
- 2017-08-24 EP EP17842455.2A patent/EP3504532B1/en active Active
- 2017-08-24 ES ES17842455T patent/ES2992526T3/es active Active
-
2022
- 2022-06-07 US US17/834,542 patent/US12140516B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7058013B2 (ja) | 2022-04-21 |
| US12140516B2 (en) | 2024-11-12 |
| CA3034608A1 (en) | 2018-03-01 |
| EP3504532A1 (en) | 2019-07-03 |
| US20200158611A1 (en) | 2020-05-21 |
| AU2017316997B2 (en) | 2022-06-30 |
| EP3504532A4 (en) | 2020-04-22 |
| AU2017316997A1 (en) | 2019-03-14 |
| EP3504532B1 (en) | 2024-08-21 |
| US11397145B2 (en) | 2022-07-26 |
| WO2018035569A1 (en) | 2018-03-01 |
| US20220299415A1 (en) | 2022-09-22 |
| JP2019525196A (ja) | 2019-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Downie | Automated tear film surface quality breakup time as a novel clinical marker for tear hyperosmolarity in dry eye disease | |
| Best et al. | Clinical evaluation of the Oculus Keratograph | |
| Gumus et al. | Noninvasive assessment of tear stability with the tear stability analysis system in tear dysfunction patients | |
| Tomlinson et al. | Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques | |
| Tian et al. | Assessment of ocular biomechanics using dynamic ultra high-speed Scheimpflug imaging in keratoconic and normal eyes | |
| Fuller et al. | Noninvasive tear breakup times and ocular surface disease | |
| Koh et al. | Correlation between corneal biomechanical indices and the severity of keratoconus | |
| Wei et al. | Assessment of lower tear meniscus | |
| Szczesna et al. | Predicting dry eye using noninvasive techniques of tear film surface assessment | |
| US12140516B2 (en) | Diagnostic methods and device | |
| Lanza et al. | Evaluation of corneal deformation analyzed with a Scheimpflug based device | |
| Baghdasaryan et al. | Analysis of ocular inflammation in anterior chamber—involving uveitis using swept-source anterior segment OCT | |
| Cardigos et al. | Tear meniscus and corneal sub-basal nerve plexus assessment in primary Sjögren syndrome and Sicca syndrome patients | |
| Chan | and Diagnostics | |
| Nichols et al. | Clinical assessments of dry eye disease: tear film and ocular surface health | |
| JP6169375B2 (ja) | 眼科測定方法、眼科測定装置および被検物質の評価方法 | |
| Napoli et al. | Evaluation of the adhesive properties of the cornea by means of optical coherence tomography in patients with meibomian gland dysfunction and lacrimal tear deficiency | |
| Rinert et al. | Accuracy of a new noninvasive automatic ocular surface analyzer for the diagnosis of dry eye disease—Two-gate design using healthy controls | |
| Akkaya et al. | Comparison of the corneal biomechanical properties, optic nerve head topographic parameters, and retinal nerve fiber layer thickness measurements in diabetic and non-diabetic primary open-angle glaucoma | |
| Cui et al. | Visualization of the precorneal tear film using ultrahigh resolution optical coherence tomography in dry eye | |
| JP5542821B2 (ja) | 眼等の層システムにおける蛍光を正確にプロットするための方法 | |
| Eroglu et al. | Is optical coherence tomography an effective device for evaluation of tear film meniscus in patients with acne rosacea? | |
| Chen et al. | Comprehensive assessment of ocular parameters for identifying diagnostic indicators of diabetic peripheral neuropathy | |
| KR102200958B1 (ko) | 비침습적 결막 미소순환 측정 장치 | |
| Bandlitz et al. | Advances in tear film assessment |